ARE Patent Law Alert:
IN SAS INSTITUTE INC. V. IANCU, U.S. SUPREME COURT DETERMINES THAT PTAB MUST ISSUE A FINAL WRITTEN DECISION ADDRESSING ALL CHALLENGED CLAIMS IN IPR PROCEEDINGS
On April 24, 2018, the Supreme Court of the United States issued a 5-4 opinion in SAS Institute Inc. v. Iancu, No. 16-969, 584 U.S. ____ (2018). In this Decision, the Court reversed the decision of the United States Court of Appeals for the Federal Circuit (“Federal Circuit”) and held that “the petitioner in an inter […]
In The Press:
IPWATCHDOG Turns To Partner Charles R. Macedo For Insight on SAS Institute Decision
SAS: When the Patent Office institutes IPR it must decide patentability of all challenged claims By Renee C. Quinn Yesterday the United States Supreme Court issued decisions in both Oil States v. Green Energyand SAS Institute v. Iancu. In Oil States the Supreme Court upheld the constitutionality of inter partes review (see here and
In The Press:
PTAB Finds N5 Technologies Patent to be Unpatentable Following Challenge from Askeladden
Askeladden successfully proves that all eleven claims of the mobile authentication patent were unpatentable. Askeladden is represented by Amster Rothstein and Ebenstein LLP. Available Here.
Patent Law Alert:PTAB ISSUES A GUIDANCE ON MOTIONS TO AMEND IN VIEW OF FEDERAL CIRCUIT’S AQUA PRODUCTS DECISION
On November 22, 2017, the Patent Trial and Appeal Board (“PTAB”) issued a guidance on motions to amend filed in inter partes review (“IPR”) and post-grant review (“PGR”) proceedings following the Federal Circuit’s en banc decision in Aqua Products, Inc. v. Matal, 872 F.3d 1290 (Fed. Cir. 2017) (https://www.uspto.gov/sites/default/files/documents/guidance_on_motions_to_amend_11_2017.pdf?utm_campaign=subscriptioncenter&utm_content=&utm_medium=email&utm_name=&utm_source=govdelivery&utm_term=) (“the Guidance”). In the Guidance, the […]
In The Press:Askeladden Advocates against Tribal Sovereign Immunity in Patent Review Proceedings
New York, NY – Askeladden filed an amicus curiae brief on Friday that presents arguments opposing the Saint Regis Mohawk Tribe’s motion to dismiss a series of inter partes reviews (IPRs) of Restasis® patents. The Tribe invoked Tribal Sovereign Immunity as a basis for its motion. Available Here:
Exploring Viability Of ‘Diagnose And Treat’ Method Claims
Law360’s Expert Analysis Exploring Viability Of ‘Diagnose And Treat’ Method Claims The enforceability of single claims that cover the steps of both diagnosing and treating a patient is discussed in view of Cleveland Clinic Foundationv. True Health Diagnostics LLC[1], which held that the claims in U.S. Patent No. 9,170,260[2] were not infringed under either contributory infringement or […]